Database for Interstitial Lung Disease

Launched by MEDICAL UNIVERSITY OF GRAZ · Jan 12, 2021

Keywords

ClinConnect Summary

This clinical trial is focused on creating a detailed database for people who are at risk for Interstitial Lung Disease (ILD), which affects the lungs and can lead to breathing problems. The study aims to set up a screening program to identify patients who may develop ILD in the future. They are currently looking for participants aged 18 and older who have a known condition that puts them at risk for ILD. However, individuals under 18 or those with serious health issues that significantly shorten their life expectancy are not eligible to join.

If you qualify and decide to participate, you will help researchers collect important information that could improve understanding and treatment of ILD. Participants can expect to be involved in regular assessments and screenings as part of this program. Overall, this study is a key step toward better prevention and management of lung diseases, and your involvement could make a real difference in how these conditions are understood and treated in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age: ≥ 18 years
• • patients with a known systemic disease bearing a risk for ILD
• • signed informed consent (for prospective part)
• Exclusion Criteria:
• • Age \< 18 years
• • comorbidities severely limiting life-expectancy (e.g. severe cardiovascular conditions, malignant disease)